Last reviewed · How we verify
ferrous fumarate with ascorbic acid
ferrous fumarate with ascorbic acid is a Iron supplement with vitamin C enhancer Small molecule drug developed by Pharmacosmos A/S. It is currently FDA-approved for Iron deficiency anemia.
Ferrous fumarate provides bioavailable iron for hemoglobin synthesis, while ascorbic acid enhances iron absorption by maintaining it in the reduced ferrous state.
Ferrous fumarate with ascorbic acid is used to treat iron-deficiency anemia. It is also being studied as a potential treatment for various types of cancer, including ovarian, cervical, and uterine cancer, although its effectiveness for these conditions is not yet established.
At a glance
| Generic name | ferrous fumarate with ascorbic acid |
|---|---|
| Sponsor | Pharmacosmos A/S |
| Drug class | Iron supplement with vitamin C enhancer |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Mechanism of action
Iron deficiency anemia results from insufficient iron for red blood cell production. Ferrous fumarate is an iron salt that delivers ferric iron to the gastrointestinal tract for absorption. Ascorbic acid (vitamin C) acts as a reducing agent and chelating agent, improving ferrous iron bioavailability and absorption efficiency in the intestine.
Approved indications
- Iron deficiency anemia
Common side effects
- Gastrointestinal upset (nausea, constipation, abdominal discomfort)
- Dark stools
- Epigastric discomfort
- Diarrhea
Key clinical trials
- Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy (NA)
- The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age (NA)
- The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome (NA)
- Nutritional Educational Program On Therapy in Iron Deficiency Anemia (NA)
- Prebiotic GOS and Lactoferrin With Iron Supplements (NA)
- Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PHASE4)
- Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years (NA)
- Effects of Enhancers and Inhibitors on Absorption From Iron Supplements (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ferrous fumarate with ascorbic acid CI brief — competitive landscape report
- ferrous fumarate with ascorbic acid updates RSS · CI watch RSS
- Pharmacosmos A/S portfolio CI
Frequently asked questions about ferrous fumarate with ascorbic acid
What is ferrous fumarate with ascorbic acid?
How does ferrous fumarate with ascorbic acid work?
What is ferrous fumarate with ascorbic acid used for?
Who makes ferrous fumarate with ascorbic acid?
What drug class is ferrous fumarate with ascorbic acid in?
What development phase is ferrous fumarate with ascorbic acid in?
What are the side effects of ferrous fumarate with ascorbic acid?
Related
- Drug class: All Iron supplement with vitamin C enhancer drugs
- Manufacturer: Pharmacosmos A/S — full pipeline
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Iron deficiency anemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing